Dupont Capital Management’s Savara SVRA Stock Holding History

Dupont Capital Management’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-112,342	Closed	-$238K	–	1415
2020 Q1	$238K	Buy	+112,342	New	+$308K	0.01%	957

Other funds holding SVRA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dupont Capital Management's SVRA Position: Q2 2020 in Review

Dupont Capital Management sold out of Savara (SVRA) in Q2 2020, closing a stake of 112,342 shares — an estimated $238K sold.

Dupont Capital Management first reported a position in SVRA in Q1 2020 and held it in 1 quarter. The position peaked at $238K in Q1 2020. 73 funds tracked by Wall St. Rank hold SVRA as of Q2 2020.

Dupont Capital Management reported no remaining Savara position as of Q2 2020 after selling out during the quarter.
Dupont Capital Management sold 112,342 Savara shares in Q2 2020, an estimated $238K.
Dupont Capital Management first reported a position in Savara in Q1 2020 and held it in 1 quarter.
Dupont Capital Management's Savara position peaked at $238K in Q1 2020.
73 funds tracked by Wall St. Rank held Savara as of Q2 2020.

Based on Dupont Capital Management's 13F filing for Q2 2020, filed 24 Jul 2020.